Table 1.
Authors | Heart Failure Type | Main Findings |
---|---|---|
Alla et al. [32] | HF vs. HHD with T2DM vs. HC | PIIINP levels were higher in HF and HHD with T2DM than HC PIIINP levels were higher in HF than HHD with T2DM |
Barasch et al. [58] | HFrEF vs. HFpEF | Associated with HFrEF and HFpEF |
Cicoira et al. [52] | HFmrEF, single arm | Decreased survival with PIIINP > 4.7 μg/L |
Martos et al. [51] | HFpEF, single arm | Increased PIIINP |
Plaksej et al. [63] | HF vs. HC | Increased levels in NYHA class III and IV |
Zannad et al. [50] | HFrEF, single arm | Decreased survival with PIIINP > 3.85 μg/L |
Zile et al. [59] | HHD and HFrEF vs. HC | Elevated PIIINP |
Klappacher et al. [47] | DCM vs. HC | Decreased survival with PIIINP > 7 μg/L |
Fassbach et al. [64] | HCM vs. HC | Increased PICP in patients with HCM |
Michalski et al. [61] | HFrEF vs. HFpEF | Strong negative correlation of PIIINP with LV strains |
Multi-Ethnic Study of Atherosclerosis (MESA) [62] | HFrEF vs. HFpEF | Elevated PIIINP |
Nagao et al. [49] | Acute HF, single arm | High PIIINP did not correlate with significant excess risk for outcome |
Sato et al. [53] | DCM, single arm | Elevated PIIINP levels associated with decreased survival rate |
Poulsen et al. [54] | HF vs. HC | Increased PIIINP level > 5 μg/L is an independent predictor of cardiac death and in-hospital development of HF |
Nikolov et al. [55] | HFmrEF vs. HC | Increased PIIINP |
Schwartzkopff et al. [60] | DCM vs. HC | Independent predictors of mortality |
NYHA, New York Heart Association; DCM, dilated cardiomyopathy; HF, heart failure not specified by ejection fraction; HFrEF, heart failure with reduced ejection fraction; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; HC, healthy control; T2DM, type 2 diabetes mellitus.